Inductive Bio
Brooklyn, US · Founded 2021 · Delaware corporation · 10 known investors
Inductive Bio builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers, combining computational chemistry with expertise in translating complex drug programs from preclinical to clinical stages.
Founders & leadership
Investors · 10
AlleyCorpNew York · $1M – $5M
Andreessen HorowitzMenlo Park · $500K – $50M
Coalition OperatorsDover · $500K
Lux CapitalNew York · $100K – $100M
Obvious VenturesSan Francisco · $250K – $6Mvia Vishal Vasishth · led
Alley Robotics VenturesreportedCohasset · $500K – $2Mvia Abe Murray · inferred
Axial VCreportedSan Francisco · $100K – $5M
Bessemer Venture PartnersreportedRedwood City · $5M – $100M
Characterreported · 2 sourcesMilwaukee · $2M
S32reportedPalo Alto
Reported raises · per SEC filings
Form D private placements▶$25.1MraisedMay 2025 · 10 investors · Other TechnologyRule 506(b)
▶$25.1MraisedMay 2025 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin Edward BirnbaumExecutive Officer, Director
- Joshua Daniel HaimsonExecutive Officer, Director
- Rohan GaneshDirector
- Offering amount
- $25.1M
- Amount sold
- $25.1M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Inductive Bio Raises $25M to Scale AI Platform for Predicting Drug Behavior Before Synthesisbiopharmatrend.com · 2025
- Inductive Bio Raises $25M Series A to Transform Small Molecule Drug Discovery with Industry-Wide AI Platformprnewswire.com · 2025
- Inductive Bio Raises $25M in Series A Fundingfinsmes.com · 2025
- Inductive Bio Emerges from Stealth, Unveiling an ML Platform to Accelerate Compound Optimization in Drug Discovery - BioSpacebiospace.com · 2023
- Inductive Bio Raises $4.3M in Seed Fundingfinsmes.com · 2023


